{\rtf1\ansi\deff0\deftab360

{\fonttbl
{\f0\fswiss\fcharset0 Arial}
{\f1\froman\fcharset0 Times New Roman}
{\f2\fswiss\fcharset0 Verdana}
{\f3\froman\fcharset2 Symbol}
}

{\colortbl;
\red0\green0\blue0;
}

{\info
{\author Biblio 7.x}{\operator }{\title Biblio RTF Export}}

\f1\fs24
\paperw11907\paperh16839
\pgncont\pgndec\pgnstarts1\pgnrestart
Naviglio S, Lacorte D, Lucaf\'f2 M, Cif\'f9 A, Favretto D, Cuzzoni E, Silvestri T, Mucelli MPozzi, Radillo O, Decorti G, Fabris M, Bramuzzo M, Taddio A, Stocco G, Alvisi P, Ventura A, Martelossi S. Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study. J Pediatr Gastroenterol Nutr 2019;68(1):37-44.\par \par De Iudicibus S, Lucaf\'f2 M, Vitulo N, Martelossi S, Zimbello R, De Pascale F, Forcato C, Naviglio S, Di Silvestre A, Gerdol M, Stocco G, Valle G, Ventura A, Bramuzzo M, Decorti G. High-Throughput Sequencing of microRNAs in Glucocorticoid Sensitive Paediatric Inflammatory Bowel Disease Patients. Int J Mol Sci 2018;19(5)\par \par Naviglio S, Giuffrida P, Stocco G, Lenti MVincenzo, Ventura A, Corazza GRoberto, Di Sabatino A. How to predict response to anti-tumour necrosis factor agents in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2018;12(8):797-810.\par \par Lucaf\'f2 M, Franca R, Selvestrel D, Curci D, Pugnetti L, Decorti G, Stocco G. Pharmacogenetics of treatments for inflammatory bowel disease. Expert Opin Drug Metab Toxicol 2018;14(12):1209-1223.\par \par Lucaf\'f2 M, Di Silvestre A, Romano M, Avian A, Antonelli R, Martelossi S, Naviglio S, Tommasini A, Stocco G, Ventura A, Decorti G, De Iudicibus S. Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease. Basic Clin Pharmacol Toxicol 2018;122(1):87-93.\par \par Franca R, Favretto D, Granzotto M, Decorti G, Rabusin M, Stocco G. Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives. Curr Med Chem 2017;24(11):1050-1065.\par \par Stocco G, Martelossi S, Arrigo S, Barabino A, Aloi M, Martinelli M, Miele E, Knafelz D, Romano C, Naviglio S, Favretto D, Cuzzoni E, Franca R, Decorti G, Ventura A. Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2017;23(4):628-634.\par \par Abate MValentina, Stocco G, Devescovi R, Carrozzi M, Pierobon C, Valencic E, Lucaf\'f2 M, Di Silvestre A, d'Adamo P, Tommasini A, Decorti G, Ventura A. Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis. Blood Cells Mol Dis 2016;59:97-9.\par \par Pelin M, De Iudicibus S, Londero M, Spizzo R, Rossi SDei, Martelossi S, Ventura A, Decorti G, Stocco G. Thiopurine Biotransformation and Pharmacological Effects: Contribution of Oxidative Stress. Curr Drug Metab 2016;17(6):542-9.\par \par Pastore S, Stocco G, Moressa V, Zandon\'e0 L, Favretto D, Malus\'e0 N, Decorti G, Lepore L, Ventura A. 5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis. Rheumatol Int 2015;35(4):619-27.\par \par Pastore S, Stocco G, Favretto D, De Iudicibus S, Taddio A, d'Adamo P, Malus\'e0 N, Addobbati R, Decorti G, Lepore L, Ventura A. Genetic determinants for methotrexate response in juvenile idiopathic arthritis. Front Pharmacol 2015;6:52.\par \par Cuzzoni E, De Iudicibus S, Franca R, Stocco G, Lucaf\'f2 M, Pelin M, Favretto D, Pasini A, Montini G, Decorti G. Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome. Pharmacogenomics 2015;16(14):1631-48.\par \par Stocco G, Lanzi G, Yue F, Giliani S, Sasaki K, Tommasini A, Pelin M, Martelossi S, Ventura A, Decorti G. Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis?. Curr Drug Metab 2015;17(1):91-8.\par \par Pelin M, De Iudicibus S, Fusco L, Taboga E, Pellizzari G, Lagatolla C, Martelossi S, Ventura A, Decorti G, Stocco G. Role of oxidative stress mediated by glutathione-s-transferase in thiopurines' toxic effects. Chem Res Toxicol 2015;28(6):1186-95.\par \par Franca R, Stocco G, Favretto D, Giurici N, Decorti G, Rabusin M. Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children. Int J Mol Sci 2015;16(8):18601-27.\par \par Stocco G, Pelin M, Franca R, De Iudicibus S, Cuzzoni E, Favretto D, Martelossi S, Ventura A, Decorti G. Pharmacogenetics of azathioprine in inflammatory bowel disease: a role for glutathione-S-transferase?. World J Gastroenterol 2014;20(13):3534-41.\par \par Stocco G, De Iudicibus S, Franca R, Addobbati R, Decorti G. Personalized therapies in pediatric inflammatory and autoimmune diseases. Curr Pharm Des 2012;18(35):5766-75.\par \par De Iudicibus S, Stocco G, Martelossi S, Londero M, Ebner E, Pontillo A, Lionetti P, Barabino A, Bartoli F, Ventura A, Decorti G. Genetic predictors of glucocorticoid response in pediatric patients with inflammatory bowel diseases. J Clin Gastroenterol 2011;45(1):e1-7.\par \par Stocco G, Crews KR, Evans WE. Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status. Expert Opin Drug Saf 2010;9(1):23-37.\par \par Paugh SW, Stocco G, Evans WE. Pharmacogenomics in pediatric leukemia. Curr Opin Pediatr 2010;22(6):703-10.\par \par Stocco G, Londero M, Campanozzi A, Martelossi S, Marino S, Malus\'e0 N, Bartoli F, Decorti G, Ventura A. Usefulness of the measurement of azathioprine metabolites in the assessment of non-adherence. J Crohns Colitis 2010;4(5):599-602.\par \par }